SFN (1.0 and 2.5 μM) treatment of prostate cancer cells from TRAMP mice (Transgenic Adenocarcinoma of the Mouse Prostrate) and TRAMP C1 cells indicated that SFN plays a role in detoxification by decreasing NRF2 promoter methylation. This evidence concerns the gene SFN and prostate carcinoma.